• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用米色小鼠建立胞内分枝杆菌病急性感染模型:初步结果

An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results.

作者信息

Gangadharam P R, Edwards C K, Murthy P S, Pratt P F

出版信息

Am Rev Respir Dis. 1983 May;127(5):648-9. doi: 10.1164/arrd.1983.127.5.648.

DOI:10.1164/arrd.1983.127.5.648
PMID:6846942
Abstract

The development of an acute infection model of Mycobacterium intracellulare disease in Beige mice (C57B1/6J-bgJ/bgJ) was investigated. Intravenous injection of 1 x 10(7) viable colony-forming units of M. intracellulare strain 571-8 produced a 1,000-fold increase in the number of mycobacteria recovered from the lungs and spleens after 28 days of infection. More importantly, 40% of the beige mice died from this infection, as was determined from histopathologic sections and bacterial culturing.

摘要

研究了米色小鼠(C57B1/6J-bgJ/bgJ)细胞内分枝杆菌病急性感染模型的建立。静脉注射1×10⁷个细胞内分枝杆菌菌株571-8的活菌落形成单位,感染28天后,从肺和脾中回收的分枝杆菌数量增加了1000倍。更重要的是,通过组织病理学切片和细菌培养确定,40%的米色小鼠死于这种感染。

相似文献

1
An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results.利用米色小鼠建立胞内分枝杆菌病急性感染模型:初步结果
Am Rev Respir Dis. 1983 May;127(5):648-9. doi: 10.1164/arrd.1983.127.5.648.
2
Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.小鼠鸟分枝杆菌-胞内分枝杆菌慢性感染的实验性化疗
Am Rev Respir Dis. 1984 Mar;129(3):453-9. doi: 10.1164/arrd.1984.129.3.453.
3
Experimental infections with Mycobacterium intracellulare.
Rev Infect Dis. 1981 Sep-Oct;3(5):973-8. doi: 10.1093/clinids/3.5.973.
4
Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters.非结核分枝杆菌感染的流行病学。IV. 细胞内分枝杆菌从天然水体中的优先雾化。
Am Rev Respir Dis. 1983 Oct;128(4):652-6. doi: 10.1164/arrd.1983.128.4.652.
5
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice.阿奇霉素和克拉霉素对米色小鼠非结核分枝杆菌的活性。
Antimicrob Agents Chemother. 1994 Jul;38(7):1455-9. doi: 10.1128/AAC.38.7.1455.
6
The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice.
J Med Microbiol. 1980 Nov;13(4):535-40. doi: 10.1099/00222615-13-4-535.
7
Bacteriological characterization of a Mycobacterium parascrofulaceum strain isolated from a Chinese pneumonia patient.从一名中国肺炎患者分离出的副结核分枝杆菌菌株的细菌学特征
Int J Infect Dis. 2014 Aug;25:82-7. doi: 10.1016/j.ijid.2014.01.023. Epub 2014 May 20.
8
Postulated sources of Mycobacterium intracellulare and Mycobacterium scrofulaceum infection: isolation of mycobacteria from estuaries and ocean waters.
Am Rev Respir Dis. 1979 Dec;120(6):1385-8. doi: 10.1164/arrd.1979.120.6.1385.
9
Epidemiology of infection by nontuberculous mycobacteria. VI. Identification and use of epidemiologic markers for studies of Mycobacterium avium, M. intracellulare, and M. scrofulaceum.非结核分枝杆菌感染的流行病学。VI. 用于鸟分枝杆菌、胞内分枝杆菌和瘰疬分枝杆菌研究的流行病学标志物的鉴定与应用。
Am Rev Respir Dis. 1986 Jul;134(1):39-43. doi: 10.1164/arrd.1986.134.1.39.
10
The bone marrow in disseminated Mycobacterium avium-intracellulare infection.播散性鸟分枝杆菌-胞内分枝杆菌感染中的骨髓
Am J Clin Pathol. 1985 Apr;83(4):463-8. doi: 10.1093/ajcp/83.4.463.

引用本文的文献

1
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.改进治疗嗜沫分枝杆菌的现有工具:药物组合评估及感染和化疗小鼠模型的特征分析。
J Antimicrob Chemother. 2013 Mar;68(3):659-65. doi: 10.1093/jac/dks421. Epub 2012 Nov 5.
2
Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice.小鼠全身性鸟分枝杆菌复合群感染后的脑部侵袭及慢性中枢神经系统感染
Infect Immun. 2000 May;68(5):2979-84. doi: 10.1128/IAI.68.5.2979-2984.2000.
3
Activities of poloxamer CRL-1072 against Mycobacterium avium in macrophage culture and in mice.
泊洛沙姆CRL - 1072在巨噬细胞培养物和小鼠中对鸟分枝杆菌的活性。
Antimicrob Agents Chemother. 1999 Dec;43(12):2898-903. doi: 10.1128/AAC.43.12.2898.
4
Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.嗜肺军团菌在卡氏棘阿米巴中的细胞内生长影响单核细胞进入机制并增强其毒力。
Infect Immun. 1999 Sep;67(9):4427-34. doi: 10.1128/IAI.67.9.4427-4434.1999.
5
Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.Y-3118、左氧氟沙星和氧氟沙星单独或与乙胺丁醇联合应用对鸟分枝杆菌复合群的体外、人巨噬细胞内及米色小鼠体内活性。
Antimicrob Agents Chemother. 1996 Mar;40(3):546-51. doi: 10.1128/AAC.40.3.546.
6
Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.氯法齐明的脂质体包封可降低体外和体内毒性,并提高播散性鸟分枝杆菌-胞内分枝杆菌复合感染米色小鼠模型的治疗效果。
Antimicrob Agents Chemother. 1996 Aug;40(8):1893-902. doi: 10.1128/AAC.40.8.1893.
7
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.KRM-1648单独使用或与乙胺丁醇和卡那霉素或克拉霉素联合使用对米色小鼠细胞内分枝杆菌感染的活性。
Antimicrob Agents Chemother. 1996 Feb;40(2):429-32. doi: 10.1128/AAC.40.2.429.
8
Mycobacterium avium complex infection in mice: lack of exacerbation after LP-BM5 murine leukemia virus infection.小鼠鸟分枝杆菌复合群感染:LP - BM5鼠白血病病毒感染后无病情加重情况
Infect Immun. 1996 Apr;64(4):1203-7. doi: 10.1128/iai.64.4.1203-1207.1996.
9
Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection.鸟分枝杆菌感染小鼠的免疫反应性:感染过程中T细胞亚群比例和抗体产生的变化
Clin Exp Immunol. 1995 Dec;102(3):523-8. doi: 10.1111/j.1365-2249.1995.tb03847.x.
10
The Mycobacterium avium complex.鸟分枝杆菌复合体
Clin Microbiol Rev. 1993 Jul;6(3):266-310. doi: 10.1128/CMR.6.3.266.